Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.
McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, Gorwood P, Ho R, Kasper S, Kennedy SH, Ly-Uson J, Mansur RB, McAllister-Williams RH, Murrough JW, Nemeroff CB, Nierenberg AA, Rosenblat JD, Sanacora G, Schatzberg AF, Shelton R, Stahl SM, Trivedi MH, Vieta E, Vinberg M, Williams N, Young AH, Maj M. McIntyre RS, et al. Among authors: kasper s. World Psychiatry. 2023 Oct;22(3):394-412. doi: 10.1002/wps.21120. World Psychiatry. 2023. PMID: 37713549 Free PMC article.
Effects of bilateral sequential theta-burst stimulation on functional connectivity in treatment-resistant depression: First results.
Stöhrmann P, Godbersen GM, Reed MB, Unterholzner J, Klöbl M, Baldinger-Melich P, Vanicek T, Hahn A, Lanzenberger R, Kasper S, Kranz GS. Stöhrmann P, et al. Among authors: kasper s. J Affect Disord. 2023 Mar 1;324:660-669. doi: 10.1016/j.jad.2022.12.088. Epub 2023 Jan 2. J Affect Disord. 2023. PMID: 36603604 Free article. Clinical Trial.
Age as a moderating factor of treatment resistance in depression.
Kautzky A, Bartova L, Fugger G, Dold M, Souery D, Montgomery S, Zohar J, Mendlewicz J, Fabbri C, Serretti A, Rujescu D, Kasper S. Kautzky A, et al. Among authors: kasper s. Eur Psychiatry. 2023 Apr 20;66(1):e35. doi: 10.1192/j.eurpsy.2023.17. Eur Psychiatry. 2023. PMID: 37078509 Free PMC article.
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders.
Himmerich H, Lewis YD, Conti C, Mutwalli H, Karwautz A, Sjögren JM, Uribe Isaza MM, Tyszkiewicz-Nwafor M, Aigner M, McElroy SL, Treasure J, Kasper S; WFSBP Task Force on Eating Disorders. Himmerich H, et al. Among authors: kasper s. World J Biol Psychiatry. 2023 Apr 24:1-64. doi: 10.1080/15622975.2023.2179663. Online ahead of print. World J Biol Psychiatry. 2023. PMID: 37350265 Review.
Increased left dorsolateral prefrontal cortex density following escitalopram intake during relearning: a randomized, placebo-controlled trial in healthy humans.
Vanicek T, Reed MB, Seiger R, Godbersen GM, Klöbl M, Unterholzner J, Spurny-Dworak B, Gryglewski G, Handschuh P, Schmidt C, Kraus C, Stimpfl T, Rupprecht R, Kasper S, Lanzenberger R. Vanicek T, et al. Among authors: kasper s. Ther Adv Psychopharmacol. 2022 Nov 17;12:20451253221132085. doi: 10.1177/20451253221132085. eCollection 2022. Ther Adv Psychopharmacol. 2022. PMID: 36420117 Free PMC article.
Silexan for treatment of anxiety and depression in the context of COVID-19.
Bartova L, Dold M, Fugger G, Weidenauer A, Rujescu D, Kasper S. Bartova L, et al. Among authors: kasper s. Eur Neuropsychopharmacol. 2023 May;70:47-48. doi: 10.1016/j.euroneuro.2023.02.015. Epub 2023 Feb 23. Eur Neuropsychopharmacol. 2023. PMID: 36867894 Free PMC article. No abstract available.
1,314 results